Physician Insights: New Approvals - Ipilimumab | Hematology Oncology Education Lab

Tell us what you think about Healio

Hematology/Oncology

Loading...

Sign in for a personal experience.

Customized content served to meet your interests.

All Specialties
Hematology/Oncology

Healio › Hematology/Oncology › Education Lab/CME

VIDEO
Physician Insights: New Approvals
We caught up with leading experts and attendees during HemOnc Today’s Melanoma Meeting in New York to discuss some of the hot topics in melanoma this year. Watch the videos to learn more about how the recent release of ipilimumab may change your practice.

Ipilimumab

Sanjiv S. Agarwala, MD, Bethlehem, PA: Dr. Agarwala is the Chief of Medical Oncology and Hematology at St. Luke's Cancer Center in Bethlehem, Pennsylvania and a Professor of Medicine at Temple University in Philadelphia, Pennsylvania.

Peter Prieto, MD, New Haven, CT: Dr. Prieto is a Resident at Yale-New Haven Hospital in New Haven, Connecticut.

Allan C. Halpern, MD, MSc, New York, NY: Dr. Halpern is the Chief of Dermatology Service at Memorial-Sloan Kettering Cancer Center in New York, New York.